Skip to main content
Premium Trial:

Request an Annual Quote

Susan Robinson, Stewart Parker, Barrie Carter

Premium
Targeted Genetics has appointed Susan Robinson as its president and CEO.
 
Robinson replaces Stewart Parker, who resigned last week. The company also said that CSO Barrie Carter has resigned, although a replacement has not been named.
 
Robinson had previously served as vice president of business development for Targeted Genetics. Before joining the company, she was director of business development at Genzyme Molecular Oncology.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.